N/A
N=68
Institutional Audit of the Use of Intravenous Acetaminophen in Infants Undergoing Pyloromyotomy
Pyloric Stenosis
Bottom Line
View on ClinicalTrials.gov: NCT02359305 ↗Enrolled (actual)
68
Serious AEs
0.0%
Results posted
Feb 2018
Primary outcome: Primary: Acetaminophen Dosage — 8.6; 30.7 mg/kg
Study Design & Population
- Study type
- Observational
- Phase
- N/A
- Interventions
- Acetaminophen (Drug)
- Age
- Pediatric, Adult, Older Adult
- Sex
- All
- Sponsor
- Arlyne Thung
- Primary completion
- Jul 2016
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Acetaminophen Dosage |
8.6; 30.7 | — |
| PRIMARY Average FLACC Pain Score in the PACU |
0.3; 0.6 | — |
| SECONDARY PACU Time |
48; 50.4 | — |
Summary
This is a retrospective chart review. The objective of the current study is to determine the analgesic efficacy and side effect profile of intravenous acetaminophen when administered to infants undergoing pyloromyotomy. In addition, recovery characteristics of infants who were administered intravenous acetaminophen will be compared to infants who did not receive intravenous acetaminophen to determine if there were any appreciable differences with regard to postoperative discomfort, PACU time, time to oral feeds and hospital discharge.
Eligibility Criteria
Inclusion Criteria
- patients who presented for pyloromyotomy
Exclusion Criteria
- none
Data sourced from ClinicalTrials.gov (NCT02359305). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.